# IncobotulinumtoxinA for Provoked Vestibulodynia With Overactive Pelvic Floor Muscle Dysfunction

> **NCT07486830** · PHASE2 · RECRUITING · sponsor: **Center for Vulvovaginal Disorders** · enrollment: 54 (estimated)

## Conditions studied

- Provoked Vestibulodynia

## Interventions

- **DRUG:** Incobotulinum Toxin A
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07486830
- **Lead sponsor:** Center for Vulvovaginal Disorders
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02-27
- **Primary completion:** 2026-12-20
- **Final completion:** 2027-03-03
- **Target enrollment:** 54 (ESTIMATED)
- **Last updated:** 2026-03-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07486830

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07486830, "IncobotulinumtoxinA for Provoked Vestibulodynia With Overactive Pelvic Floor Muscle Dysfunction". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07486830. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*